CapEx at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s capex?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported capex of $86K in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s capex changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s capex increased by 330.0% year-over-year, from $20K to $86K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s capex?
- Over 3 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s capex has grown at a -26.9% compound annual growth rate (CAGR), from $353K to $138K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.